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Rheumatoid arthritis (RA) is a chronic disorder characterized by systemic 
inflammation caused by autoimmune dysfunction in the synovial joints, leading to 
the destruction of articular cartilage and joint deformity. Patients afflicted with 
RA develop various signs and symptoms including articular and extra-articular 
manifestations accompanying disease progression. Interstitial lung disorder (ILD) 
is one of the most common clinical manifestations of the lung among RA patients. 
The prevalence of ILD in RA patients (RA-ILD) is about 30% in RA patient 
demonstrated evidence of abnormalities consistent with ILD by high-resolution 
computed tomography (HRCT) in various reports. RA-ILD demonstrates a poor 
prognosis and one of the main causes of death in RA patients both in Japan.  
Advanced age, male gender, increased severity of joint involvements and 
drugs (i.e. leflunomide and methotrexate) have been shown to be risk factors for 
RA-ILD. Human leukocyte antigen (HLA) is known to be associated with RA. 
HLA-DRB1*0101, HLA-DRB1*0401, HLA-DRB1*0404, HLA-DRB1*0405 and 
shared epitope (SE) are well known risk alleles among RA. HLA-DRB1*04, SE and 
HLA-DQB1*04 were significantly associated with a decreased risk of RA-ILD.  
HLA-DRB1*16, DR2 serological group and HLA-DQB1*06 showed an increased risk 
of RA-ILD.  
Genome-wide association study (GWAS) has emerged as an effective genetic 
screening tool to reveal associations between specific polymorphisms and 
corresponding phenotypes utilizing a large number of single nucleotide 
polymorphisms (SNPs). However, a comprehensive study using GWAS has yet to be 
conducted for RA-ILD. The present study performed GWAS to identify the 
susceptibility genes or SNPs that are associated with RA-ILD among Japanese.  
This study was a collaborative effort between our laboratory and the 
Sagamihara National Hospital in Kanagawa, Japan. 620 RA patients were 
recruited from 10 hospitals. All patients fulfilled the revised American College of 
Rheumatology 1987 criteria for the classification of RA. RA patients were examined 
for the diagnosis of ILD, based on the findings by chest radiography or HRCT. To 
avoid interaction between the therapeutic drug and RA-ILD, drug induced 
interstitial lung disorder (DI-ILD) patients were excluded from this study.  
Genome-wide SNP genotyping was conducted using the Affymetrix Axiom 
Genome-Wide ASI 1 Array containing more than 600,000 SNP loci that were 
optimized to maximize the coverage for Asian populations. 
After SNP quality control (QC), sample QC, principal component analysis 
and identical by descend ascertainment, genome-wide association tests were 
conducted using 169 patients that have RA with ILD and 294 patients with RA 
without ILD.  
The association test between RA with ILD and RA without ILD identified 
11 SNPs with minimum p-values of less than 5 × 10-6 according to the five models 
(allelic, dominant, recessive, genotypic model and Cochran-Armitage trend test). No 
SNP showed a significant p-value as calculated by Bonferroni correction. The region 
19q13.11 and 12q24.11 showed p-values of less than 1 × 10-6. Therefore, SNPs 
within these regions were applied to the subsequent analysis, including regional 
imputation analysis, eQTL analysis by GENEVAR and assessment of functional 
annotations of SNPs in the region by Haploreg v2. 
 The SNP in the region of 19q13.11, showed the lowest p-value (p-value: 5.98 
× 10-7 calculated by Cochran-Armitage trend test). The nearest gene, which encodes 
a zinc finger protein, was located 150 kb upstream of the SNP. From a regional 
imputation analysis, 13 SNPs showed lower p-values than that of the genotyped 
SNP and the lowest p-value was 1.87 × 10-7. One SNP, which was in high LD (r2= 
0.82) with the SNP, was shown to exhibit a promoter chromatin state and was 
located in DNase hypersensitivity site. The other SNP in the region 12q24.11 
showed an association (p-value: 6.86 × 10-7 and odds ratios (OR): 0.37 under 
dominant model). The gene containing this SNP in 11th intron encodes a 
transporter-like protein that is expressed in the entire brain.  
 To exclude the effect of HLA class II region, a sub-group analysis was 
performed. By focusing on HLA-DRB1*04 positive patients among those having RA 
with ILD, association tests were conducted for 85 HLA-DRB1*04 positive RA 
patients with ILD and 197 HLA-DRB1*04 positive RA patients without ILD. The 
SNP in the region 7p21.3 showed an association (p-value: 4.2 × 10-7 and OR: 2.71), 
which could not be detected before division. One of the SNP in the region of 7p21.3 
was reported to show an association with protein expression level of TGF-β1. Next, 
association tests were conducted for 84 HLA-DRB1*04 negative RA patients with 
ILD and 97 HLA-DRB1*04 negative RA patients without ILD. The SNP in the 
region 10q23.1 located on the second intron showed an association (p-value: 2.72 × 
10-6 and OR: 5.77). The gene containing the SNP is a member of the neuregulin 
(NRG) gene family, which encodes ligands for the transmembrane tyrosine kinase 
receptors. 
 To reveal possible overlap of susceptibility SNPs to RA or pulmonary 
fibrosis (PF) with those of RA-ILD, reported RA and PF susceptibility SNPs were 
selected and compared with results derived from the present study. Firstly, 
association results of RA-ILD and reported RA susceptibility SNPs were compared. 
The susceptibility SNPs of the present study did not overlap with RA susceptibility 
SNPs. Secondly, 12 PF susceptibility SNPs from previous reports were selected to 
compare to the association results of the present study. The susceptibility SNPs of 
the present study did not overlap with PF susceptibility SNPs. 
This study detected novel SNPs which might cause RA-ILD and subgroup 
analysis divided by presence/absence of HLA-DRB1*04 revealed those two groups 
had different predispositions for RA-ILD. From the comparison of the previously 
reported associations of RA and PF with the results of RA-ILD GWAS, sharing 
susceptibility SNPs were not observed. 
